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Abstract
Background: The total health expenditure (as a percentage of GDP) and health outcomes in the region of South
Asian Association for Regional Cooperation (SAARC) and Association for South East Asian Nations (ASEAN) are lower
than that of the OECD region and the world. This study investigated the relationship between different types of
healthcare expenditures (public, private and total) and three main health status outcomes - life expectancy at birth,
crude death rate and infant mortality rate - in the region.
Methodology: Using the World Bank data set for 15 countries over a 20-year period (1995–2014), a panel data
analysis was conducted where relevant fixed and random effect models were estimated to determine the effects
of healthcare expenditure on health outcomes. The main variables studied were total health expenditure, public
health expenditure, private health expenditure, GDP per capita, improved sanitation, life expectancy at birth, crude
death rate and infant mortality rate.
Results: Total health expenditure, public health expenditure and private health expenditure significantly reduced
infant mortality rates, and, the extent of effect of private health expenditure was greater than that of public health
expenditure. Private health expenditure also had a significant role in reducing the crude death rate. Per capita income
growth and improved sanitation facilities also had significant positive roles in improving population health in
the region.
Conclusions: Health expenditure in the SAARC-ASEAN region should be increased as our results indicated that it
improved the health status of the population in the region. Public sector health funds must be appropriately and
efficiently used, and accountability and transparency regarding spending of public health funds should be ensured.
Finally, government and private institutes should implement appropriate strategies to improve sanitation facilities.
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Introduction
Enriched human capital is considered an important fac-
tor for achieving desired economic growth and develop-
ment in any country [1, 2]. According to the neoclassical
growth model, growth in human capital, in terms of
education and health, positively affects per capita in-
come in the long run [2]. Bloom and Canning [3, 4] and
Bloom et al. [5] identified four mechanisms through
which healthier individuals contribute to the economy:
(i) at the workplace, healthier individuals are more pro-
ductive and thus generally earn a higher income, (ii) they
are able to retire later and take less sick leave due to
overall good health and so they are able to work longer,
(iii) they are more likely to invest in their own education
and training which then enhances their productivity; and
(iv) they are likely to save and invest more with the ex-
pectation of a longer life. Therefore, health is an integral
part of sustainable development, and attempts for its
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improvement should always be the main development
goal of a nation [6]. Furthermore, good health ensures
economic security for the individuals themselves and
their families [7], and provides a sense of empowerment
that adds value to human life [8].
It is vital for all countries to appropriately invest in
their health sector. Evidence shows that investing in
health significantly benefits the economy [5, 9]. For ex-
ample, a WHO report [10] revealed that for every in-
crease in life expectancy at birth by 10%, the economic
growth rate increased by 0.35% per year. Similarly, ill
health is considered as a huge financial burden, and it is
the major cause of 50% of the growth differential be-
tween developed and developing countries. Despite the
importance of health investment, health expenditure in
developing regions like South Asian Association for Re-
gional Cooperation (SAARC) and Association for South
East Asian Nations (ASEAN) is still under-represented
in government budgets due to scarcity of resources [11].
Realizing the importance of population health and its
contribution to the national economy, researchers have
been conducting studies to explore the link between
healthcare expenditure and health sector outcomes for
more than two decades. However, most of these studies
are based on developed countries (see, for example, An-
derson and Poullier [12], Babazono and Hillman [13],
Beger and Messer [14], Cochrane et al. [15], Crémieux et
al. [16], Crémieux et al. [17], Elola et al. [18], Hitiris and
Possnett [19], Or [20], Nixon and Uimann [21], Wolfe
and Gabay [22]); but such studies on developing coun-
tries/regions are limited. Furthermore, to the best of our
knowledge, no such study that uses macro data, has yet
been conducted in the SAARC-ASEAN region. In
addition, the health sectors and health expenditure pat-
terns have changed significantly during the last decade.
Therefore, a recent study that uses macro data and is
specific to the SAARC-ASEAN region is warranted. This
was our main rationale for conducting current research
on a panel of 15 countries that will contribute to this
gap in the literature. Furthermore, the debate on the re-
lationship between health care expenditure and health
outcomes is still inconclusive (Novignon et al. [1]). This
study will help mitigate this debate by providing new
evidence from a new region. Additional contributions of
this study are that: the endogeneity issue of the con-
cerned variables has been addressed, and the effects of
healthcare expenditures on three health status indicators
have been investigated as well, whilst most other studies
investigated the effects of only one or two health status
indicators. Hence, our study has a broader coverage.
The aims of this study were: (i) to explore the impact
of total health care expenditure on three health out-
comes - life expectancy at birth, crude death rate and in-
fant mortality rate in the SAARC-ASEAN region, and
(ii) to investigate the differentiated influences of public
versus private health care expenditure on these health
outcomes. We have also explored the impact of two con-
trolled variables: real GDP per capita and improved sani-
tation facilities. The rationale for selecting the three
health outcomes (life expectancy at birth, crude death
rate, infant mortality rate) was that the current status of
these health outcomes is relatively poor in the countries
of the SAARC-ASEAN region, compared to that of de-
veloped countries and the world in general (see Fig. 1).
The sections below in this paper are structured as fol-
lows: section 2 reviews the past empirical literature; sec-
tion 3 briefly highlights the regional profiles; section 4
describes the methodology, data and model; section 5 pre-
sents empirical results; section 6 discusses the results; and,
section 7 concludes the paper with policy implications.
Literature review
Past empirical studies on the relationship between health-
care expenditure and health sector outcomes provide con-
flicting views. For example, Rana, et al. [23], Anand and
Ravallion [24], Patricio et al. [25] and Imoughele and
Ismaila [26] revealed a positive relationship between pub-
lic healthcare expenditure and health sector performance
for 30 OECD countries, Sri Lanka, Russia and Nigeria, re-
spectively. On the other hand, Filmer and Pritchett [27],
Musgrove [28] and Kim and Moody [29] found no rela-
tionship between these variables. Filmer and Pritchett [27]
identified that rather than public healthcare expenditure,
the level of poverty, income inequality, female education
and other socio-economic factors were the main deter-
mining factors of child mortality. Furthermore, a World
Bank study on Indian states using panel data for the
period 1980–1999 found no effects of healthcare expend-
iture on infant mortality rate [30], which is similar to the
findings of Burnside and Dollar [31]. Some other studies
like Zakir and Wunnava [32], Nolte and Mckec [33] and
Young [34] also found no significant and consistent rela-
tionship between health spending and health outcomes.
In a separate study in Brazil, Alves and Belluzzo [35]
employed static panel data models to explore the deter-
minants of infant mortality rate using census data for
the period of 1970–2000. They found that education
level, sanitation and poverty were significantly related to
infant mortality rates. The same outcomes were also ob-
served by the studies of Meara [36], Currie and Moretti
[37] and Filmer [38].
In relation to the positive effects of healthcare expend-
iture on health outcomes, more empirical evidence has
been found worldwide. In a study on 47 African coun-
tries between 1999 and 2004, Anyanwu and Erhijakpor
[9] found that total healthcare expenditure significantly
affected health outcomes: for every 1% increase of total
health care expenditure per capita, there was a 2.1 and
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2.2% decrease in under-five and infant mortality rates,
respectively. Similarly, Akinkugbe and Mohanoe [39]
also found a significant effect of healthcare expenditure,
along with other variables, on health outcomes.
Cross-country data analysis by Gupta et al. [40] on the
relationship between public health expenditure and
health status showed significant and stronger effects for
the poorer population. In another study on 50 devel-
oping and transition countries, Gupta et al. [41] re-
vealed that health expenditure reduced child mortality
rates in 1994. Similarly, Issa and Ouattara [42] found
a strong inverse relationship between health spending
and infant mortality rate in a panel study of 160
countries, where they also segregated health expend-
iture into public and private spending. The same re-
sults on infant and child mortality rates were also
observed by Paxson and Schady [43] and Wang [44],
in relation to private health expenditure and public
health expenditure, respectively. Significant inverse re-
lationships between health care expenditure and mor-
tality rates were also revealed by: Berger and Messer
[14] in 20 OECD countries over the period of 1960–
1992, Gani [45] in Pacific Island countries over the
period of 1990–2002, Farag [46] in the Eastern Medi-
terranean region during the period of 1995–2006, and
Novignon, and Lawanson [47] in sub-Saharan Africa
over the period of 1995–2011.
Furthermore, Barenberg et al. [48], Maruthappu et al.
[49] and Kumar et, al. [50] found similar results of the
inverse relationship between public health spending and
infant/child mortality rate for India, 176 countries and
India, respectively. Maruthappu et al. [49] noted that
low income countries, compared with higher income
countries, experienced higher infant/child mortality rates
due to reduction in public health spending. Kumer et al.
[50] found a marginal effect of − 0.13 on under-five mor-
tality and − 0.08 on infant mortality in relation to public
health spending.
Recently, Arthur and Oaikhenan [51] conducted a
study on 40 sub-Saharan African (SSA) countries using
World Bank data, where they found an inelastic but sig-
nificant effect of health expenditure on health outcomes.
Their findings indicated that health expenditure reduced
mortality rates and improved life expectancy marginally.
They found that mortality rate was related to public
health expenditure, whereas life expectancy was linked
with private health expenditure. The study of Ashiabi et
al. [52] on 40 SSA countries also found similar results,
implying that public health expenditure improved infant
and under-five mortality rates. The findings of Farahani
et al. [53] in India also showed that a 10% increase in
public health spending reduced the death rate by about
2% across all age groups. In another study on East
African countries, Bein et al. [54] found a strong positive
Fig. 1 Health status outcomes for selected regions (selected years). Source: Word Development Indicators, World Bank, 2016
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effect of total health expenditure on total life expectancy,
and an inverse association between healthcare expend-
iture and mortality rate, implying the improvement of
health outcomes with increased spending. The positive
relationship between health expenditure and life expect-
ancy was also revealed by the study of Jaba et al. [55] for
all groups of countries regardless of their income level;
Ranabhat et al. [56] also observed a positive effect of
universal health coverage, where health expenditure is a
major component, on the life expectancy in 193 coun-
tries. In contrast, Heuvel and Olaroiu [57] did not find
health expenditure to be a main determinant of life ex-
pectancy in 31 European countries.
The above literature review indicates that there is a
lack of studies, specific to the SAARC-ASEAN region,
on the relationship between health care expenditure and
health outcomes, particularly a study that uses macro
data. Moreover, instead of examining one health out-
come indicator, the present study has examined three
health outcome indicators separately. Therefore, this
study has a much broader scope, and it is unique in
using macro data in the SAARC-ASEAN region, which
will certainly contribute to the existing gap in the litera-
ture and have important policy implications.
Brief profile of the SAARC-ASEAN region
The economic, political and social structures of the coun-
tries in the SAARC-ASEAN region are more or less simi-
lar, and therefore, comparable. SAARC or South Asia has
a population of 1, 744 million, which is 23.75% of the
world population. The ASEAN or South-East Asian popu-
lation is 625 million, which is 8.8% of the world popula-
tion. Together the SAARC-ASEAN region comprises
32.55% of the world’s population, and 5.81% of the world’s
GDP [58]. Hence, the region is a significant player in the
world stage, and therefore, any research that seeks to im-
prove the economy and population health of that region is
critical. The present study addresses this need.
Table 1 highlights the trend of health care expenditure
of South Asia (SAARC countries) and South East Asia
(ASEAN countries) against the OECD group and the
world for selected years. It is observed that although
total health expenditure (as percentage of GDP) has an
increasing trend over the years in the SAARC-ASEAN
regions, it is still far below the OECD region’s and the
world’s health expenditure trends. In 2014, while the
share of total health expenditure was 12.36% in OECD
countries and 9.97% in the world, this was only 4.37% in
South Asia and 4.72% in South East Asia. Between 2005
and 2014, the growth rate of total health expenditure in
OECD countries was 12.5%, but it was only 7% in South
Asia and 11% in South East Asia.
The condition of public health expenditure (as a per-
centage of government expenditure) is very poor in
South Asia. It is less than one third of that of the OECD
countries, and around half of that of South East Asian
countries. It is also only one third of the world average
public health expenditure. Although South East Asia has
a better health expenditure profile than South Asia, it is
still half of that of the OECD and world average (see
Table 1). The growth rate of public health expenditure
over the years is unconvincing for South Asia (a very
small increase from 4.80% in 2005 to 5.25% in 2014)
against the increase of South East Asia (an increase from
8.18% in 2005 to 10.42% in 2014), and the OECD coun-
tries (an increase from 16.23% in 2005 to 17.76% in
2014). It is plausible that poverty in the region, especially
in South Asia, may be the main reason for low public
health expenditure. This raises major concern for ex-
pected heath status outcomes in the region.
Out of pocket health expenditure (as a percentage of
private expenditure on health) in both South Asia and
South East Asia has decreased slightly over the years,
along the lines of OECD countries. However, this out of
pocket spending is still very high in SAARC and ASEAN
regions compared to the OECD and world average. Out
of pocket health expenditure in South Asia and South
East Asia is approximately double that of the world aver-
age. While this share of out of pocket health expenditure
was only 36.01% in the OECD group in 2014, it was
89.41% for South Asia and 80.07% for South East Asia.
The study of Rancic and Jakovljevic [59] also found very
high proportion of private expenditure on health, driven
mainly by out-of-pocket spending, for Bangladesh and
Table 1 Trend in health care expenditures for selected regions (selected years)
Regions Total health expenditure
(% of GDP)
Public health expenditure
(% of government expenditure)
Out of pocket health expenditure
(% of private expenditure on health)
1995 2005 2014 1995 2005 2014 1995 2005 2014
South Asia 3.76 4.07 4.37 4.43 4.80 5.25 92.17 89.36 89.41
South East Asia 3.69 4.24 4.72 7.64 8.18 10.42 86.41 84.60 80.07
OECD group 9.23 10.99 12.36 13.41 16.23 17.76 41.42 37.58 36.01
World 8.52 9.80 9.97 – 15.39a 15.61b 45.90 43.33 45.80
Note: a data for 2010
b data for 2011
Source: World Development Indicators, World Bank, 2016
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the Philippines among the Next − 11 emerging coun-
tries. This high proportion of out-of-pocket health
spending is a major concern, as it will aggravate the
existing poverty and compromise the welfare of the vast
population of the SAARC-ASEAN region.
Although the study of Jakovljevic and Getzen [60]
noted the increasing trend of greater investment in
health care particularly in India, Bangladesh, Pakistan,
Indonesia, the Philippines and Vietnam, it is still far
below than some other comparable countries. For ex-
ample, total health expenditure (% of GDP) of India was
the lowest (3.97%) among the BRICS countries in 2013.
The per capita government and private expenditures on
health were also the lowest in India among the BRICS
countries which were just $69 and $146, respectively
[61]. Dieleman et al. [62] forecasted that, in low-income
countries, per capita health spending would remain low
at $154 in 2030 and $195 in 2040.
Figure 1 shows the trend of the health status outcomes
of the SAARC and ASEAN regions in comparison with
the OECD group and the world. It is observed that al-
though total life expectancy at birth (years) has an in-
creasing trend over the years in the SAARC-ASEAN
region, it is always lower than that of the OECD group.
In particular, total life expectancy in South Asia is always
lower than that of the world average, highlighting the
poor health status in the region. Whilst the world aver-
age total life expectancy is 71.45 years in 2014, it is only
68.12 years in South Asia.
Infant mortality rate per 1000 live births has improved
tremendously in the SAARC-ASEAN region over the
years. It has decreased from 80.10 per 1000 live births in
1995 to 43.30 per 1000 live births in 2014 in South Asia.
In South East Asia, it has decreased to 20.26 per 1000 live
births in 2014 from 42.44 per 1000 live births in 1995.
However, it is still much higher than the OECD average
(6.09 per 1000 live births) and the world average (32.60
per 1000 live births) in 2014, especially for South Asia, im-
plying again the poor health status in the study region.
The crude death rate per 1000 people in the region
has a similar trend to the OECD group and the world.
Over the years, the crude death rate has been declining
slightly. In 2014, it was 7.16 per 1000 people for South
Asia, 6.27 per 1000 people for South East Asia, 8.10 per
1000 people for the OECD group and 7.75 per 1000
people for the world. These crude death rates may be
misrepresentations of actual crude death rates in South
Asia vs. South-East Asia vs. OECD countries vs. the
world. For example, OECD countries, in general, have a
larger ageing population and the population of
SAARC-ASEAN regions mostly consist of young people.
Hence comparatively, the crude death rate may be
over-represented in OECD countries due to a larger pro-
portion of the population being elderly.
Methodology
In the literature, different estimation methods (e.g. cross
sectional analysis, panel, autoregressive distributed lag
model, etc.) have been used to analyse the relationship
between healthcare expenditure and health status out-
comes. This paper used a panel data estimation method.
For studies that cover multiple countries, panel data es-
timation is the best approach to follow. Furthermore,
panel data analysis has the following advantages over
cross sectional analysis and time series analysis: i) panel
data provides a more accurate inference of model pa-
rameters via more degrees of freedom and more sample
variability; hence econometric estimates are improved,
efficient and reliable [63], ii) panel data controls the
impact of omitted variables, iii) panel data takes into ac-
count the inter-individual differences, and, iv) different
data periods can be used for different countries with
unbalanced panel data. Therefore, our chosen method of
a panel data analysis for this research is justified.
Following Novignon et al. [1], we adopted a health
outcome model as follow:
yit ¼ Hitβþ εt ; t ¼ 1…::T ð1Þ
εt ¼ μZþ v ð2Þ
where yit is a vector of dependent variables in country i
at time t, H is a vector of exogenous variables, including
the constant, and β is a vector of coefficients. εt is a vec-
tor of random error terms. Baltagi et al. [64] propose
two components of the error process such as time vari-
ant and reminder error process. The error term is spatial
weights matrix, Z, and contains spatial autocorrelation
parameter, μ.
We have also considered the effects of two controlled
variables: real per capita income and improved sanita-
tion facilities. These two variables are chosen based on
earlier literature and the availability of data in the coun-
tries of study. Economic theory suggests that people with
a higher level of income have increased spending cap-
acity (as purchasing power increases) on better quality
and healthy food, as well as on better health services. It
is also expected that good sanitation facilities can pro-
vide better health outcomes. Therefore, to investigate
the effects of health care expenditure, real per capita in-
come and sanitation on health outcomes, we specify the
following equation:
HSit ¼ αþ β1THEit þ β2GDPit þ β3SANit þ εit ð3Þ
where, HS denotes the three health outcome variables,
namely, total life expectancy at birth (years), infant mor-
tality rate (per 1000 live births) and crude death rate
(per 1000 people). THE is total health expenditure (as %
of GDP), and GDP represents gross domestic product
Rahman et al. Globalization and Health          (2018) 14:113 Page 5 of 11
per capita (constant 2005 US$) and SAN is improved
sanitation facilities.
Total health expenditure is the summation of two types of
health expenditure: public and private health expenditures.
Public health expenditure includes recurrent and capital
spending from government budgets and social or compul-
sory insurance funds. On the other hand, private health ex-
penditure includes private health insurance premiums,
direct payments or out-of-pocket health expenditure [1, 65].
Both private and public health expenditures have different
effects on health status. For example, an increase in
out-of-pocket health expenditure, which is a type of private
health expenditure, reduces the individual’s spending ability
on other goods and services (including other health goods
and services). This may lead to more poverty and thus the
cycle continues with increased poor health status due to lack
of money to spend on additional health goods and services.
On the other hand, an increase in public health expenditure
may worsen government budget deficit, but it will decrease
the burden of individual private health expenditure. In-
creased public health expenditure contributes to improved
societal health, which allows for improved human capital
that eventually leads to higher economic growth [66]. Thus
we analysed the individual impact of these two components
(public and private health expenditures) on health outcomes
using the following equation:
HSit ¼ αþ β1PUBit þ β2PRIit þ β3GDPit
þ β4SANit þ εit ð4Þ
where, PUB and PRI represent public health expenditure
and private health expenditure, respectively. All variables
are in natural logarithmic form. The subscripts i and t
represent country and time, respectively.
Firstly, we ran a fixed effect model generalised least
squares (GLS) and a random effect model GLS (with
cross-section weights). Baltagi et al. [64] argue that the
random effect model is more suitable when the error
term is considered not serially correlated with the re-
minder error and there is no spatial serial dependence of
error terms. Cameron and Trivedi [67] argue that fixed
effect may be used to control endogeneity in panel data
where endogeneity arises owing to time-invariant omit-
ted variables. We conducted the Hausman Test to inves-
tigate whether the fixed effect or random effects model
was the most appropriate model. In addition, we
addressed the potential endogeneity issue by adopting
the Panel Generalized Method of Moments (GMM).
Arellano and Bond [68] propose that the use of instru-
mental variable GMM mitigates the endogeneity prob-
lem with explanatory variables. Furthermore, GMM is
very useful in estimating extensions of the basic unob-
served effects [69].
Initially, we collected annual data from 1960 to 2014
(55 years) from the World Development Indicators
(WDI), which is a World Bank database for 17 countries
of the South Asia (SAARC) and South East Asia
(ASEAN) regions. These countries were Bangladesh,
Bhutan, Brunei Darussalam, Cambodia, India, Indonesia,
Lao PDR, Malaysia, Maldives, Myanmar, Nepal, Pakistan,
Philippines, Singapore, Sri Lanka, Thailand and Vietnam.
The chosen variables for collected data were total life ex-
pectancy at birth (years), infant mortality rate (per 1000
live births), crude death rate (per 1000 people), per
capita real GDP, improved sanitation facilities (% of
population with access), total health expenditure (% of
GDP), public health expenditure (% of government
expenditure) and private health expenditure i.e. out-
of-pocket health expenditure (% of private expenditure
on health). Due to lack of data for all countries and for
all years, we had to limit the study to 15 countries
excluding Myanmar and Brunei Darussalam for the
period of 1995–2014 (20 years).
Results
Table 2 provides the mean and standard deviation of life
expectancy at birth (LIF), mortality rate (MOR), death
rate (DEA), per capita real GDP (GDP), total health
expenditure (THE), public health expenditure (PUP),
private health expenditure (PRI) and improved sanitation
facilities (SAN).
The effects of health care expenditures on life expectancy
The effect of health care expenditure on life expectancy
was investigated using the fixed and random effect
models, and the results are reported in Table 3.
The effects of health care expenditures on death rate
The results regarding the effects of health care expendi-
tures on death rate are noted in Table 4 below.
The effect of health care expenditures on infant mortality
rate
The estimated results of health care expenditures on in-
fant mortality rate are presented in Table 5 below.
Addressing the potential endogeneity issue
We have estimated the panel GMM results to address
the potential endogeneity problem. The obtained results
are noted in Table 6 below. We found similar results
of the fixed and random effect models reported in
Table 3–5 above.
Discussion
Table 2 shows that the highest (79.54) and the lowest
(61.32) mean of LIF were reported in Singapore and Lao
PDR, respectively. The highest and lowest mean death
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rates were 8.77 and 4.33 in Lao PDR and Maldives, re-
spectively. The lowest mean value of mortality (2.73)
and the highest mean values of GDP and SAN
(29,060.14 and 99.84, respectively) were reported in
Singapore. Whilst the lowest mean of total health ex-
penditure was reported in Indonesia (2.50), it was the
highest in Maldives (7.86). The highest and the lowest
means of public health expenditure were in Thailand
(16.72) and India (4.39), respectively. The highest mean
private health expenditure was in Bhutan (98.07), and
the lowest mean was in the Maldives (65.26). In
Cambodia, the availability of sanitation facilities was
minimal among the sample countries.
Table 3 results reveal that an increase of total health
expenditures had no impact on life expectancy at birth
(LIF), consistent with the findings of Filmer and
Pritchett [27] and Barlow and Vissandjee [70], but con-
tradicting the findings of Novignon et al. [1]. In
addition, public health care expenditure (PUB) and pri-
vate health care expenditure (PRI) also had no impact
on life expectancy at birth. This may be explained by
the fact that life expectancy is affected by other factors,
such as diet, lifestyle and environment, which are not
directly related to the health care system [21]. Per
capita income (GDP) and sanitation (SAN) were found
to improve life expectancy at birth. The corrected ran-
dom effect Hausman specification test confirmed that
fixed effect estimate was more appropriate (Chi-Sq.
statistic is 31.87) in this estimate. The fixed effect
model was significant with an R-square of 98%, and
F-statistic of 885.
Table 2 Descriptive statistics of variables
LIF DEA MOR GDP THE PRI PUB SAN
Bangladesh
Mean 67.37 6.43 53.57 509.00 2.73 94.83 7.87 50.06
Std. Dev. 2.98 0.89 15.29 121.80 0.30 2.25 0.96 6.13
Bhutan
Mean 63.85 7.79 48.37 1343.95 5.59 98.07 12.26 37.89
Std. Dev. 4.26 1.55 14.93 420.86 1.30 2.25 3.26 8.86
Cambodia
Mean 62.06 8.14 58.36 468.01 5.83 94.30 9.73 24.13
Std. Dev. 4.44 1.75 22.47 161.03 0.83 8.62 3.82 10.27
India
Mean 64.33 8.25 57.46 768.06 4.29 89.99 4.39 30.10
Std. Dev. 2.33 0.68 11.99 244.75 0.18 1.69 0.30 5.85
Indonesia
Mean 67.06 7.24 35.30 1336.29 2.50 74.82 5.00 51.38
Std. Dev. 1.17 0.06 8.47 259.47 0.39 1.56 0.75 6.03
Lao PDR
Mean 61.32 8.77 72.63 504.03 3.63 78.71 6.11 42.55
Std. Dev. 3.18 1.53 14.30 158.28 1.03 10.62 2.15 16.96
Malaysia
Mean 73.43 4.58 7.95 5587.07 3.51 76.59 5.60 92.96
Std. Dev. 0.85 0.17 1.69 929.23 0.45 1.98 0.58 2.40
Maldives
Mean 72.74 4.31 25.03 4223.96 7.86 65.26 15.49 86.86
Std. Dev. 3.78 0.88 15.09 703.87 2.05 15.06 4.04 9.74
Nepal
Mean 64.76 7.80 49.76 325.83 5.85 84.81 11.19 28.93
Std. Dev. 3.47 1.25 14.50 52.21 0.44 7.35 2.52 9.66
Pakistan
Mean 63.82 8.34 81.43 693.06 2.83 87.07 4.13 44.90
Std. Dev. 1.44 0.67 8.96 78.54 0.27 5.65 0.51 10.59
Philippines
Mean 67.18 6.28 27.77 1230.63 3.76 81.75 8.12 66.80
Std. Dev. 0.67 0.20 3.17 206.24 0.58 2.78 0.88 3.94
Singapore
Mean 79.54 4.48 2.73 29,060.14 3.49 94.70 9.04 99.84
Std. Dev. 2.03 0.24 0.67 5641.49 0.69 1.17 2.13 0.21
Sri Lanka
Mean 72.73 6.69 12.39 1319.45 3.66 84.04 7.30 85.87
Std. Dev. 2.02 0.46 2.88 374.54 0.29 4.59 1.62 6.14
Thailand
Mean 72.10 7.09 16.24 2883.15 4.93 68.76 16.72 92.18
Std. Dev. 1.53 0.42 4.05 534.58 0.89 9.77 4.85 1.45
Vietnam
Mean 73.94 5.65 23.44 705.23 5.60 89.97 8.48 60.49
Std. Dev. 1.15 0.11 4.01 209.81 0.80 6.26 2.47 9.92
Notes: LIF = Life expectancy at birth, DEA = Crude death rate, MOR = infant
mortality rate; GDP = Gross domestic product (per capita), THE = Total health
expenditure, PUB = Public health expenditure, PRI = Private health expenditure,
SAN = Sanitation facilities
Table 3 Effects of health care expenditures on life expectancy
at birth (LIF)
Model Fixed Effect Random Effect
C 3.3306
(142.61)a
3.3777
(59.17)a
3.3807
(144.15)a
3.4243
(60.30)a
LNTHE 0.0011
(0.23)
0.0055
(1.23)
LNPUB −0.0015
(− 0.45)
0.0001
(0.04)
LNPRI −0.0093
(− 0.88)
− 0.0088
(− 0.85)
LNGDP 0.0740
(13.67)a
0.0750
(14.21)a
0.0608
(12.56)a
0.0631
(13.19)a
LNSAN 0.0911
(16.32)a
0.0890
(15.72)a
0.1004
(19.03)a
0.0972
(17.97)a
R-squared 0.9805 0.9805 0.8888 0.8891
F-Statistic 885.05 885.51 772.96 579.11
Observations 294 294 294 294
Cross-section included 15 15 15 15
Notes: a, **, and
*denote significance level at 1, 5 and 10%, respectively. Figures in the parentheses
are t-statistics
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Table 4 reveals that total health expenditure (THE)
had a positive impact on death rate; an increase in THE
was more likely to increase death rate with a 1% level of
significance. When we split the THE into public and pri-
vate, public health expenditure (PUB) was found to
increase death rate; whereas, private health care expend-
iture (PRI) reduced death rate. Whilst public health care
expenditure increased the death rate by about 0.06 in
both the fixed and random effects models, private health
care expenditure reduced death rate by 0.11 per 1000
people in the fixed and random effect models at 1%
significance level, partially consistent with the findings
of Novignon et al. [1] from sub-Saharan Africa. How-
ever, the studies of Berger and Messer [14] and Hitiris
and Possnett [19] on OECD countries revealed that
health expenditure reduced mortality rate in developed
countries. This discrepancy between our findings and
other studies may be due to the fact that there is limited
good governance for utilising public health expenditure
in SAARC-ASEAN countries. If resources in the public
sector are inefficiently used, and corruption prevails, the
likely outcomes on health status will not be achieved
[71]. Furthermore, public health care expenditure com-
pared to private health care expenditure in developing
countries are manifold; since the sign of public health
expenditure is positive, the effect of total health expend-
iture is also found positive (see Akinci et al. [72], for ex-
ample). Additionally, while per capita GDP had no effect
on death rate (DEA), improved sanitation facilities re-
duced the death rate. The corrected random effects of
Hausman specification test confirmed that the random
effect estimate was more appropriate (Chi-Sq. statistic is
5.45) in this case. The random effect model was signifi-
cant with an R-square of 79%, and F-statistic of 356.
Table 5 shows that total health care expenditure was
more likely to reduce the infant mortality rate and that a
1% increase in total health care expenditure (as percen-
tageof GDP) led to a reduction in infant mortality rate
by around 0.27 per 1000 live births in the fixed and ran-
dom effect models at a 1% significance level.. When the
total healthcare expenditure is divided into public and
private, both expenditures decreased the infant mortality
rate, as expected. Both real per capita GDP and sanita-
tion facilities reduced the infant mortality rate as well.
These results are consistent with the findings of Kumar
et al. [50], Barenberg et al. [48], Crémieux et al. [17],
Elola and Vicente [18], Novignon, et al. [1], Issa and
Ouattara [42], Paxson and Schady [43] and many others.
The extent of effect on infant mortality rate was higher
with private health expenditure (0.24) than public health
expenditure (0.09). The corrected random effect Haus-
man specification test confirmed that the random effect
estimate was more appropriate (Chi-Sq. statistic is 3.07)
in this case. The random effect model was significant
with an R-square of 85%, and F-statistic of 534.
Overall, our main results indicated that total health care
expenditure significantly reduced the number of infant
mortalities per 1000 live births. The separate effects of
public and private health expenditures on infant mortality
rate were also negative in the sample of selected countries.
While health care expenditure had no effect on life ex-
pectancy at birth, private health expenditure had an in-
verse relationship with death rate in the selected sample
countries. Here, public and private health care expendi-
tures showed conflicting effects on the death rate.
Table 4 Effects of health care expenditures on death rate (DEA)
Model Fixed Effect Random Effect
C 3.4010
(35.49)a
3.8843
(16.78)a
3.4273
(35.77)a
3.9320
(17.01)a
LNTHE 0.0910
(4.82)a
0.0861
(4.66)a
LNPUB 0.0645
(4.69)a
0.0632
(4.65)a
LNPRI −0.1065
(−2.51)b
−0.1100
(−2.60)a
LNGDP 0.0016
(0.07)
0.0111
(0.52)
−0.0063
(− 0.32)
0.0017
(0.09)
LNSAN −0.4173
(−18.20)a
− 0.4385
(−19.11)a
−0.4098
(−18.96)a
−0.4307
(− 19.56)a
R-squared 0.9637 0.9647 0.7866 0.7946
F-Statistics 430.76 417.07 356.22 279.50
Observations 294 294 294 294
Cross-section included 15 15 15 15
Notes: a, b, and * denote significance level at 1, 5 and 10%, respectively.
Figures in the parentheses are t-statistics
Table 5 Effects of health care expenditures on infant mortality
rate (MOR)
Model Fixed Effect Random Effect
C 10.1249
(52.39)a
11.3396
(22.58)a
10.0440
(47.78)a
11.2206
(22.15)a
LNTHE −0.2683
(−7.05)a
−0.2749
(−7.32)a
LNPUB −0.0833
(−2.79)a
−0.0888
(−3.00)a
LNPRI −0.2383
(−2.59)a
−0.2405
(−2.62)a
LNGDP −0.7840
(−17.51)a
−0.8579
(− 18.48)a
−0.7581
(− 18.12)a
−0.8209
(− 18.89)a
LNSAN − 0.2124
(−4.59)a
−0.1709
(− 3.43)a
−0.2332
(−5.23)a
−0.1996
(−4.14)a
R-squared 0.9893 0.9879 0.8467 0.8267
F-Statistics 1495.82 1247.25 533.76 344.70
Observations 294 294 294 294
Cross-section included 15 15 15 15
Notes: a, **, and * denote significance level at 1, 5 and 10%, respectively.
Figures in the parentheses are t-statistics
Rahman et al. Globalization and Health          (2018) 14:113 Page 8 of 11
Conclusion and policy implications
This study has explored the role of healthcare expend-
iture on three important health status outcomes: life ex-
pectancy at birth, crude death rate and infant mortality
rate, in the SAARC-ASEAN region. A panel data set of
15 countries for 20 years (1995–2014) was used. The
separate effects of private and public healthcare expendi-
tures on health outcomes were also examined. Further-
more, two control variables, GDP per capita and
improved sanitation facilities, were also added in the se-
lected models as explanatory variables.
Our findings reveal that total health expenditure had a
significant effect in reducing infant mortality rate in the
region. The separate effects of private and public health
expenditures on this health status indicator were also
negative, as expected, and statistically significant, imply-
ing that both types of healthcare expenditures are essen-
tial for improving the population’s health. However,
unlike some earlier studies, Novignon et al. [1] for ex-
ample, the extent of effect of private health expenditure
was found to be higher than that of public health ex-
penditure in the present study. This may be due to the
fact that the use of public health funds in these countries
is, in general, inefficient due to corruption and inappro-
priate governance.
Private health care expenditure also significantly de-
creased the crude death rate in the region, although
public health expenditure showed the opposite result.
Improper utilisation of public sector funds may be the
reason behind this. The present study did not find any
significant effect of healthcare expenditure on life ex-
pectancy. This may be due to the reason that life expect-
ancy depends on some other important factors such as
lifestyle, environment, individual education level, etc., for
which we have no available data.
We also found that per capita income growth rate had
significant positive effects in increasing life expectancy
and reducing infant mortality rates in the region. Im-
proved sanitation facilities also played a significant posi-
tive role in increasing life expectancy and decreasing
crude death rate and infant mortality rate.
Based on these research findings, the following pol-
icy implications may be drawn. Firstly, increases in
health expenditure is to be supported in order to im-
prove the health status of the population in the re-
gion. The amount of spending is to be more or less
close to that of the developed countries. Secondly,
proper governance and handling must be upheld for
appropriate and efficient use of public sector health
funds, and accountability and transparency must be
ensured in this regard. Thirdly, efforts should be
made and adequate policies must be adopted and exe-
cuted to increase the income level of the population
and to enable them to spend more on health goods
and services. Finally, further improved sanitation facil-
ities are to be supported by the government and pri-
vate initiatives.
The present study faced some limitations, especially
when attempt was made to include a large dataset con-
sidering a long period of time with many countries, and
involving many different variables. For example, the time
period of the dataset had to be reduced from 55 years to
20 years, and, the number of countries used from the
dataset had to be decreased to 15 from 17 countries.
Also, there was no available data on some important
variables such as diet, lifestyle, education level and envir-
onment, which could have been incorporated as ex-
planatory variables in the models. Future research
should address these limitations, though they in no way
invalidate the findings of this study.
Table 6 The results of panel Generalized Method of Moments (GMM)
Dependent variable LIF DEA MOR
C 3.3306
(149.24)a
3.3777
(84.62)a
3.4273
(35.88)a
3.8843
(19.85)a
10.1249
(68.28)a
11.3396
(25.50)a
LNTHE 0.0011
(0.27)
0.0861
(4.32)a
−0.2683
(−6.69)a
LNPUB −0.0015
(− 0.43)
0.0645
(3.86)a
−0.0833
(−2.88)a
LNPRI −0.0093
(−1.45)
−0.1065
(−3.66)a
− 0.2383
(− 2.85)a
LNGDP 0.0740
(13.54)a
0.0750
(14.41)***
−0.0063
(− 0.31)
0.0111
(0.51)
− 0.7840
(− 19.65)a
−0.8579
(−19.35)a
LNSAN 0.0911
(23.36)a
0.0890
22.05
−0.4098
(−27.80)a
− 0.4385
(− 27.61)a
−0.2124
(−4.86)a
−0.1709
(− 4.11)a
R-squared 0.9804 0.9805 0.7866 0.9646 0.9893 0.9879
Observations 294 294 294 294 294 294
Cross-section included 15 15 15 15 15 15
Notes: a, **, and * denote significance level at 1, 5 and 10%, respectively. Figures in the parentheses are t-statistics
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